Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  MRC Precision Medicine: Boosting innate T cell responses in colon cancer


   College of Medical, Veterinary and Life Sciences

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Dr Seth Coffelt, Prof Joanne Edwards  No more applications being accepted  Competition Funded PhD Project (Students Worldwide)

About the Project

Project summary:

The importance of T cells is well established in colorectal cancer, as their abundance in tumours predicts a good outcome in cancer patients. However, for the largest group of colorectal cancers – the microsatellite stable (MSS) group, which represents 80-85% of cases – T cells are largely absent from tumours. Patients with MSS tumours respond poorly to T cell checkpoint inhibitors, such as anti-PD-1. Thus, a greater understanding of how T cells are excluded from MSS tumours is required. Across the genomic landscape of MSS tumours, mutations in WNT/beta-catenin-related genes are the strongest correlative of low T cell infiltration. Thus, the overall goal of this proposal is to mechanistically dissect the interaction between WNT/beta-catenin signalling, immunosurveillance and immune escape in colon cancer. This proposal will specifically focus on intraepithelial lymphocytes (IELs), a group of gut-resident, unconventional T cells consisting of both alpha/beta T cells and gamma/delta T cells, rather than conventional, dendritic cell-educated CD8+ T cells. The Coffelt lab has discovered that IELs recognize and kill pre-cancerous gut epithelial cells. We have found that WNT signalling negatively regulates T cell interacting molecules, but downregulation of these proteins is reversible if WNT signalling is inhibited.

Project Q&A Session

Friday 9th December, 1400 hrs.

ZOOM Meeting

https://uofglasgow.zoom.us/j/84193295568?pwd=YlBDLzFVVVMyQUtrRGFYRXFiTnpMZz09

Email: [Email Address Removed] for password information. 

About the Programme

This MRC programme is joint between the Universities of Edinburgh and Glasgow. You will be registered at the host institution of the primary supervisor detailed in your project selection.

All applications should be made via the University of Edinburgh, irrespective of project location. For those applying to a University of Glasgow project, your application along with any supporting documents will be shared with University of Glasgow.

How to Apply: https://www.gla.ac.uk/colleges/mvls/graduateschool/mrcdtpprecisionmedicine/howtoapply/

Please note, you must apply to one of the projects and you must contact the primary supervisor prior to making your application. Additional information on the application process is available here: http://www.ed.ac.uk/studying/postgraduate/degrees/index.php?r=site/view&id=919

For more information about Precision Medicine visit:

http://www.ed.ac.uk/usher/precision-medicine 

Application Enquiries

Alexis Merry

[Email Address Removed]

Biological Sciences (4)

Funding Notes

Start: September 2023

Qualifications criteria: Applicants applying for an MRC DTP in Precision Medicine studentship must have obtained, or will soon obtain, a first or upper-second class UK honours degree or equivalent non-UK qualification, in an appropriate science/technology area. The MRC DTP in Precision Medicine grant provides tuition fees and stipend of at least £17,668 (UKRI rate 2022/23).

Full eligibility details are available: http://www.mrc.ac.uk/skills-careers/studentships/studentship-guidance/student-eligibility-requirements/

Enquiries regarding programme: [Email Address Removed]
Search Suggestions
Search suggestions

Based on your current searches we recommend the following search filters.